The alteration in the expression of synaptic scaffolding protein shank3 detected in the present study is consistent with shank3 mutations associated with NDD, such as ASD, ID, and schizophrenia, in several cohort studies [92,93] and with manic-like hyperkinetic behavior in transgenic mice [94,95]. The gene discussed is SHANK3; the disease is schizophrenia.